Watch DNLI. Know when insiders buy.
One email the day a filing lands. Free.
DNLI
Denali Therapeutics Inc.
18.68
−0.25 −1.32%
USD · close Oct 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
52
WATCH · insiders 34, shorts 70
Insiders, 90 days
−$364K
net selling · 0 buys, 4 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $3BP/E —DIV YIELD —FCF YIELD -14.65%REV TTM —NET INCOME −$511.5MNET CASH —52W 14.41 – 27.21SEC XBRL · TTM TO Invalid Date
Insider trading
−$364K
Net, 90 days
0 / 4
Buys / sells, 90 days
0
Distinct buyers
$0
Bought, 90 days
| Traded | Filed | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 4 | Sep 9 | Chin Peter Scott · Chief Medical Officer | Sell | 1,654 | $22.29 | $37K |
| Sep 2 | Sep 4 | Thornberry Nancy · Director | Sell | 615 | $23.74 | $15K |
| Sep 2 | Sep 4 | Thornberry Nancy · Director | Sell | 10,824 | $22.85 | $247K |
| Sep 1 | Sep 3 | Schuth Alexander O. · COFO and Secretary | Sell | 2,768 | $23.44 | $65K |
Source: SEC EDGAR Form 4 filings, pulled nightly; open-market purchases and sales only, no option exercises or grants. The tracker, all tickers.